Polygenic contributions to lithium augmentation outcomes in antidepressant non-responders with unipolar depression.

Saved in:
Bibliographic Details
Title: Polygenic contributions to lithium augmentation outcomes in antidepressant non-responders with unipolar depression.
Authors: Kraft J; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Buspavanich P; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Brandenburg Medical School Theodor Fontane, Department of Psychiatry, Psychotherapy and Psychosomatics, Campus Neuruppin, Germany.; Charité - Universitätsmedizin Berlin, Research Unit Gender in Medicine, Campus Mitte, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Institute of Sexology and Sexual Medicine, Campus Mitte, Berlin, Germany., Braun A; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Panagiotaropolou G; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Schlattmann P; Jena University Hospital, Department of Statistics, Informatics and Data Sciences, Jena, Germany., Buchbauer H; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany., Heilbron K; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany.; Current address: Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany., Heilbronner U; LMU University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG), Munich, Germany., Schulze TG; LMU University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG), Munich, Germany.; SUNY Upstate Medical University, Department of Psychiatry and Behavioral Sciences, Syracuse, NY, USA.; Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, MD, USA.; German Center for Mental Health (DZPG), partner site Munich/Augsburg, Berlin, Germany., Ripke S; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; German Center for Mental Health (DZPG), partner site Berlin/Potsdam, Berlin, Germany., Ricken R; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany., Adli M; Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Mitte, Berlin, Germany.; Fliedner Klinik Berlin, Centre for Psychiatry, Psychotherapy and Psychosomatic Medicine, Berlin, Germany.
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2025 Jan 23. Date of Electronic Publication: 2025 Jan 23.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2025.01.22.25320940